Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.

D J Wagener; W J Hoogenraad; P Rougier; A Lusinchi; B G Taal; C H Veenhof; A de Graeff; T Conroy; D Curran; T Sahmoud

doi:10.1016/0959-8049(96)00070-6

Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.

Identifier:nobleid.org/w1/20260515/BA39B9B8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BA39B9B8.svg?ark=w1%2F20260515%2FBA39B9B8)](https://nobleid.org/work/w1/20260515/BA39B9B8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.

Identifier:nobleid.org/w1/20260515/BA39B9B8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BA39B9B8.svg?ark=w1%2F20260515%2FBA39B9B8)](https://nobleid.org/work/w1/20260515/BA39B9B8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work